Literature DB >> 19620304

Nonredundant roles for B cell-derived IL-10 in immune counter-regulation.

Rajat Madan1, Filiz Demircik, Sangeetha Surianarayanan, Jessica L Allen, Senad Divanovic, Aurelien Trompette, Nir Yogev, Yuanyuan Gu, Marat Khodoun, David Hildeman, Nicholas Boespflug, Mariela B Fogolin, Lothar Gröbe, Marina Greweling, Fred D Finkelman, Rhonda Cardin, Markus Mohrs, Werner Müller, Ari Waisman, Axel Roers, Christopher L Karp.   

Abstract

IL-10 plays a central role in restraining the vigor of inflammatory responses, but the critical cellular sources of this counter-regulatory cytokine remain speculative in many disease models. Using a novel IL-10 transcriptional reporter mouse, we found an unexpected predominance of B cells (including plasma cells) among IL-10-expressing cells in peripheral lymphoid tissues at baseline and during diverse models of in vivo immunological challenge. Use of a novel B cell-specific IL-10 knockout mouse revealed that B cell-derived IL-10 nonredundantly decreases virus-specific CD8(+) T cell responses and plasma cell expansion during murine cytomegalovirus infection and modestly restrains immune activation after challenge with foreign Abs to IgD. In contrast, no role for B cell-derived IL-10 was evident during endotoxemia; however, although B cells dominated lymphoid tissue IL-10 production in this model, myeloid cells were dominant in blood and liver. These data suggest that B cells are an underappreciated source of counter-regulatory IL-10 production in lymphoid tissues, provide a clear rationale for testing the biological role of B cell-derived IL-10 in infectious and inflammatory disease, and underscore the utility of cell type-specific knockouts for mechanistic limning of immune counter-regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620304      PMCID: PMC2772089          DOI: 10.4049/jimmunol.0900185

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.

Authors:  R T Gazzinelli; M Wysocka; S Hieny; T Scharton-Kersten; A Cheever; R Kühn; W Müller; G Trinchieri; A Sher
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

2.  B lymphocyte-specific, Cre-mediated mutagenesis in mice.

Authors:  R C Rickert; J Roes; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

3.  Modified immunological status of anti-IL-10 treated mice.

Authors:  H Ishida; R Hastings; L Thompson-Snipes; M Howard
Journal:  Cell Immunol       Date:  1993-05       Impact factor: 4.868

4.  Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.

Authors:  D J Berg; R Kühn; K Rajewsky; W Müller; S Menon; N Davidson; G Grünig; D Rennick
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

5.  The role of IL-10 in human B cell activation, proliferation, and differentiation.

Authors:  K Itoh; S Hirohata
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

6.  Interferon-gamma and interleukin-10 messenger RNA are up-regulated after orthotopic liver transplantation in tolerant rats: evidence for cytokine-mediated immune dysregulation.

Authors:  E J Alfrey; D Most; X Wang; L K Lee; B Holm; N R Krieger; R K Sibley; P Huie; D C Dafoe
Journal:  Surgery       Date:  1995-08       Impact factor: 3.982

7.  Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor.

Authors:  T J Standiford; R M Strieter; N W Lukacs; S L Kunkel
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

8.  Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice.

Authors:  R D Cardin; G B Abenes; C A Stoddart; E S Mocarski
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

9.  Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice.

Authors:  S D Wolf; B N Dittel; F Hardardottir; C A Janeway
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

10.  Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3.

Authors:  F Brière; C Servet-Delprat; J M Bridon; J M Saint-Remy; J Banchereau
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  163 in total

1.  Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells.

Authors:  Gil Benedek; Jun Zhang; Ha Nguyen; Gail Kent; Hilary A Seifert; Sean Davin; Patrick Stauffer; Arthur A Vandenbark; Lisa Karstens; Mark Asquith; Halina Offner
Journal:  J Neuroimmunol       Date:  2017-06-21       Impact factor: 3.478

2.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.

Authors:  Ashutosh Chaudhry; Robert M Samstein; Piper Treuting; Yuqiong Liang; Marina C Pils; Jan-Michael Heinrich; Robert S Jack; F Thomas Wunderlich; Jens C Brüning; Werner Müller; Alexander Y Rudensky
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

Review 3.  Animal models of IBD: linkage to human disease.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  Curr Opin Pharmacol       Date:  2010-06-08       Impact factor: 5.547

4.  Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity.

Authors:  Fengdong Cheng; Hongwei Wang; Pedro Horna; Zi Wang; Bijal Shah; Eva Sahakian; Karrune V Woan; Alejandro Villagra; Javier Pinilla-Ibarz; Said Sebti; Mitchell Smith; Jianguo Tao; Eduardo M Sotomayor
Journal:  Cancer Res       Date:  2012-06-22       Impact factor: 12.701

5.  Interleukin-10 is produced by a specific subset of taste receptor cells and critical for maintaining structural integrity of mouse taste buds.

Authors:  Pu Feng; Jinghua Chai; Minliang Zhou; Nirvine Simon; Liquan Huang; Hong Wang
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

6.  Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation.

Authors:  C Andrew Stewart; Hannah Metheny; Noriho Iida; Loretta Smith; Miranda Hanson; Folkert Steinhagen; Robert M Leighty; Axel Roers; Christopher L Karp; Werner Müller; Giorgio Trinchieri
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

7.  Endocannabinoid system acts as a regulator of immune homeostasis in the gut.

Authors:  Nandini Acharya; Sasi Penukonda; Tatiana Shcheglova; Adam T Hagymasi; Sreyashi Basu; Pramod K Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

8.  Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells.

Authors:  Georgia Perona-Wright; Katja Mohrs; Frank M Szaba; Lawrence W Kummer; Rajat Madan; Christopher L Karp; Lawrence L Johnson; Stephen T Smiley; Markus Mohrs
Journal:  Cell Host Microbe       Date:  2009-12-17       Impact factor: 21.023

9.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

Review 10.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.